Initial Experience With the AngioVac Venous Drainage Cannula

Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02775565

Enrollment

Registered

2016-05-17

Start date

2016-02-29

Completion date

2017-05-31

Last updated

2017-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Disease

Brief summary

This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria to be considered enrolled in the study. The purpose of the study is to describe initial experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.

Interventions

DEVICEAngioVac

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Consecutive patients treated at each study site between February 1, 2013 and February 28, 2015 will be included.

Exclusion criteria

* Patients treated with the AngioVac venous drainage system outside of those dates.

Design outcomes

Primary

Measure	Time frame
Detailing early clinical experience with the AngioVac Venous Drainage Cannula	Experience and success is determined immediately after the procedure is completed. No subject follow up data is collected and retrospective data will be reviewed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026